HS-20090 (denosumab biosimilar)
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 23, 2023
Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
(clinicaltrials.gov)
- P1 | N=180 | Recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
March 21, 2023
Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
(clinicaltrials.gov)
- P1 | N=180 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1